Clinical Trial Update: A Phase II Trial of Cabozantinib With Patients With Refractory GCTs [Phase 2]

View source ↗

Summary

Update on a Phase II trial of cabozantinib in patients with refractory germ cell tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Non-seminomatous Germ Cell Tumor
• Ovarian Germ Cell Tumor
• Seminoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Jennifer King | Conditions: Germ Cell Tumor, Seminoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING